B-cell expansion as a precursor to splenic MZ lymphoma (MZ) and noncanonical NF-{kappa}B pathways generating marginal zone E{micro}-BCL10 mice exhibit constitutive activation of both canonical
暂无分享,去创建一个
J. Rehg | E. Tuomanen | D. Roopenian | Hongsheng Wang | H. Morse | C. Orihuela | M. Sangster | Wu Xu | Dong-Mi Shin | X. Cui | L. Xue | Q. Li | Xiaoli Cui
[1] D. Roopenian,et al. NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.
[2] K. Yeh,et al. Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma. , 2008, Blood.
[3] Uri Hershberg,et al. Frontline : Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites , 2007 .
[4] C. Berek,et al. In Vitro and In Vivo Activation Induces BAFF and APRIL Expression in B Cells1 , 2007, The Journal of Immunology.
[5] M. Du. MALT lymphoma : recent advances in aetiology and molecular genetics. , 2007, Journal of clinical and experimental hematopathology : JCEH.
[6] S. Rauser,et al. MALT1 directs B cell receptor–induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit , 2007, Nature Immunology.
[7] F. Mackay,et al. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. , 2007, Current opinion in immunology.
[8] Chen-feng Qi,et al. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. , 2007, Cancer research.
[9] H. Noels,et al. The pathogenesis of MALT lymphomas: where do we stand? , 2007, Leukemia.
[10] S. Ghosh,et al. Antigen-Receptor Signaling to Nuclear Factor κB , 2006 .
[11] D. Rawlings,et al. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes , 2006, Nature Reviews Immunology.
[12] G. Widhopf,et al. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.
[13] P. Marynen,et al. Selective Expansion of Marginal Zone B Cells in Eμ-API2-MALT1 Mice Is Linked to Enhanced IκB Kinase γ Polyubiquitination , 2006 .
[14] T. Phan,et al. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation , 2006, The Journal of experimental medicine.
[15] T. Molina,et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication , 2005, Gut.
[16] P. Marynen,et al. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation. , 2006, Haematologica.
[17] S. Tsuzuki,et al. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. , 2005, Blood.
[18] A. DeFranco,et al. Bcl10 can promote survival of antigen-stimulated B lymphocytes. , 2005, Blood.
[19] K. Yeh,et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). , 2005, Blood.
[20] A. Nicholson,et al. MALT lymphoma with t(14;18)(q32;q21)/IGH‐MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression , 2005, The Journal of pathology.
[21] T. Habermann,et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. , 2004, Blood.
[22] J. Kearney,et al. B Cell Positive Selection: Road Map to the Primary Repertoire? , 2004, The Journal of Immunology.
[23] T. Phan,et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.
[24] A. Rao,et al. Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-κB Signaling , 2004, Molecular and Cellular Biology.
[25] F. Ajchenbaum‐Cymbalista,et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. , 2004, Blood.
[26] Honglin Zhou,et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.
[27] V. Roschke,et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. , 2003, Arthritis and rheumatism.
[28] V. Dixit,et al. Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase , 2003, Science.
[29] Jürgen Ruland,et al. Differential requirement for Malt1 in T and B cell antigen receptor signaling. , 2003, Immunity.
[30] S. Morris,et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells , 2003, Nature Immunology.
[31] K. Toellner,et al. Extrafollicular antibody responses , 2003, Immunological reviews.
[32] S. Akilesh,et al. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. , 2003, Genome research.
[33] Chris Bakal,et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. , 2003, Immunity.
[34] G. Ott,et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. , 2003, Blood.
[35] R. Jonsson,et al. Attenuated Apoptosis of B Cell Activating Factor–Expressing Cells in Primary Sjögren’s Syndrome , 2003, Laboratory Investigation.
[36] S. Shinton,et al. Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development , 2003, The Journal of experimental medicine.
[37] V. Roschke,et al. BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases1 , 2002, The Journal of Immunology.
[38] N. Harris,et al. Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.
[39] D. Baltimore,et al. The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Pillai,et al. Antigen-dependent B-cell development. , 2002, Current opinion in immunology.
[41] M. Reth. Oligomeric antigen receptors: a new view on signaling for the selection of lymphocytes. , 2001, Trends in immunology.
[42] J. Kearney,et al. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.
[43] T. Mak,et al. Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube Closure , 2001, Cell.
[44] Bruce H. Horwitz,et al. Nuclear Factor κb Is Required for the Development of Marginal Zone B Lymphocytes , 2000, The Journal of experimental medicine.
[45] A. Hagemeijer,et al. Genetic abnormalities in marginal zone B‐cell lymphoma , 2000, Hematological oncology.
[46] J. Silver,et al. Positive selection of natural autoreactive B cells. , 1999, Science.
[47] J. Kearney,et al. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. , 1999, Journal of immunology.
[48] K. Lennert,et al. Splenic marginal zone lymphomas of mice. , 1999, The American journal of pathology.
[49] J.M. Adams,et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.